BioEclipse Tx Awarded Almost $8M Grant by CIRM to Fund Ongoing PI CRX100 Trial
26 Apr 2022 //
PRNEWSWIRE
BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO
26 Jan 2022 //
PRNEWSWIRE
BioEclipse to Present at Virtual H.C. Wainwright 23rd Annual Conference
10 Sep 2021 //
PRNEWSWIRE
BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100
19 Jan 2021 //
PRNEWSWIRE
BioEclipse Initiates Enrollment in Phase 1 Dose-Escalation Trial for CRX100
22 Dec 2020 //
PRNEWSWIRE
BioEclipse Therapeutics to Participate in Sachs Annual Biotech in EuropeForum
18 Sep 2020 //
BIOSPACE

Market Place
Sourcing Support